278 related articles for article (PubMed ID: 7955456)
1. Augmented 17 alpha-hydroxyprogesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours ('incidentalomas').
Seppel T; Schlaghecke R
Clin Endocrinol (Oxf); 1994 Oct; 41(4):445-51. PubMed ID: 7955456
[TBL] [Abstract][Full Text] [Related]
2. Increased 17 alpha-hydroxyprogesterone response to ACTH in silent adrenal adenoma: cause or effect?
Del Monte P; Bernasconi D; Bertolazzi L; Meozzi M; Badaracco B; Torre R; Marugo M
Clin Endocrinol (Oxf); 1995 Mar; 42(3):273-7. PubMed ID: 7758232
[TBL] [Abstract][Full Text] [Related]
3. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
[TBL] [Abstract][Full Text] [Related]
4. Impairment of 11 beta-hydroxylase but not 21-hydroxylase in adrenal 'incidentalomas'.
Reincke M; Peter M; Sippell WG; Allolio B
Eur J Endocrinol; 1997 Feb; 136(2):196-200. PubMed ID: 9116915
[TBL] [Abstract][Full Text] [Related]
5. Low basal androstenedione levels plus augmented 17alpha-hydroxyprogesterone and low dehydroepiandrosterone sulfate responses to adrenocorticotropic hormone stimulation in patients with adrenal incidentaloma.
Ozgen AG; Bayraktar F; Yilmaz C
Endocr Pract; 2001; 7(6):448-53. PubMed ID: 11747281
[TBL] [Abstract][Full Text] [Related]
6. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas.
Patócs A; Tóth M; Barta C; Sasvári-Székely M; Varga I; Szücs N; Jakab C; Gláz E; Rácz K
Eur J Endocrinol; 2002 Sep; 147(3):349-55. PubMed ID: 12213672
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma 21-deoxycorticosterone (21-DB) levels in late-onset adrenal 21-hydroxylase deficiency suggest a mild defect of the mineralocorticoid pathway.
Fiet J; Gueux B; Raux-DeMay MC; Kuttenn F; Vexiau P; Brerault JL; Couillin P; Galons H; Villette JM; Julien R
J Clin Endocrinol Metab; 1989 Mar; 68(3):542-7. PubMed ID: 2537337
[TBL] [Abstract][Full Text] [Related]
8. 17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas.
Bernini GP; Brogi G; Vivaldi MS; Argenio GF; Sgrò M; Moretti A; Salvetti A
J Endocrinol Invest; 1996 Dec; 19(11):745-52. PubMed ID: 9061508
[TBL] [Abstract][Full Text] [Related]
9. The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation.
Grossrubatscher E; Vignati F; Possa M; Lohi P
J Endocrinol Invest; 2001 Dec; 24(11):846-55. PubMed ID: 11817708
[TBL] [Abstract][Full Text] [Related]
10. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP
J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
[TBL] [Abstract][Full Text] [Related]
11. Incidental adrenal nodules: association with exaggerated 17-hydroxyprogesterone response to adrenocorticotropic hormone.
Turton DB; O'Brian JT; Shakir KM
J Endocrinol Invest; 1992 Dec; 15(11):789-96. PubMed ID: 1337905
[TBL] [Abstract][Full Text] [Related]
12. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
Pham-Huu-Trung MT; Gourmelen M; Raux-Eurin MC; Girard F
J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of 21-hydroxylase deficiency in adrenal incidentalomas - hormonal and mutation screening.
Wagnerova H; Lazúrová I; Habalová V; Dudásová D; Vrzgula A
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):272-5. PubMed ID: 18589890
[TBL] [Abstract][Full Text] [Related]
14. Pituitary-adrenocortical function in abdominal obesity of males: evidence for decreased 21-hydroxylase activity.
Hautanen A; Adlercreutz H
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):123-33. PubMed ID: 8809194
[TBL] [Abstract][Full Text] [Related]
15. Absence of nonclassical congenital adrenal hyperplasia in patients with precocious adrenarche.
Morris AH; Reiter EO; Geffner ME; Lippe BM; Itami RM; Mayes DM
J Clin Endocrinol Metab; 1989 Oct; 69(4):709-15. PubMed ID: 2550505
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of 21-hydroxylase and 11 beta-hydroxylase deficiency in adrenal incidentalomas and in subclinical Cushing's syndrome.
Dall'Asta C; Barbetta L; Libé R; Passini E; Ambrosi B
Horm Res; 2002; 57(5-6):192-6. PubMed ID: 12053092
[TBL] [Abstract][Full Text] [Related]
17. Carrier status for steroid 21-hydroxylase deficiency is only one factor in the variable phenotype of acne.
Ostlere LS; Rumsby G; Holownia P; Jacobs HS; Rustin MH; Honour JW
Clin Endocrinol (Oxf); 1998 Feb; 48(2):209-15. PubMed ID: 9579234
[TBL] [Abstract][Full Text] [Related]
18. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.
Flecchia D; Mazza E; Carlini M; Blatto A; Olivieri F; Serra G; Camanni F; Messina M
Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956
[TBL] [Abstract][Full Text] [Related]
19. Basal and adrenocorticotropic hormone-stimulated serum 17 alpha-hydroxyprogesterone in men with idiopathic infertility.
Ojeifo JO; Winters SJ; Troen P
Fertil Steril; 1984 Jul; 42(1):97-101. PubMed ID: 6327405
[TBL] [Abstract][Full Text] [Related]
20. Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization.
Sólyom J; Gács G; Keszei K; Láng K; Orley J; Petheö I; Ságodi L
Acta Endocrinol (Copenh); 1987 Jul; 115(3):413-8. PubMed ID: 3039770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
